GM1/GD1/GA1 synthase expression results in the reduced cancer phenotypes with modulation of composition and raft-localization of gangliosides in a melanoma cell line

Cancer Science

Volumn 101, Issue 9, 2010, Pages 2039-2047

  Dong, Yu ^a   Ikeda, Kazutaka ^b,c   Hamamura, Kazunori ^a   Zhang, Qing ^a   Kondo, Yuji ^a   Matsumoto, Yasuyuki ^a   Ohmi, Yuhsuke ^a   Yamauchi, Yoshio ^a   Furukawa, Keiko ^a,c,d,e   Taguchi, Ryo ^b,c   Furukawa, Koichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d CHUBU UNIVERSITY   (Japan)

^e Ministry of Education Culture Sports Science and Technology   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; COMPLEMENTARY DNA; CRK ASSOCIATED SUBSTRATE PROTEIN; GANGLIOSIDE; GANGLIOSIDE GA 1; GANGLIOSIDE GALACTOSYLTRANSFERASE; GANGLIOSIDE GD 1B; GANGLIOSIDE GD2; GANGLIOSIDE GD3; GANGLIOSIDE GM2; GANGLIOSIDE GM3; GANGLIOSIDE GT 1B; PAXILLIN; TRITON X 100; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID; BCAR1 PROTEIN, HUMAN; GANGLIOSIDE, GD1B; GANGLIOSIDE, GD3; PXN PROTEIN, HUMAN; TRISIALOGANGLIOSIDE GT1;

ARTICLE; CELL GROWTH; CELL INVASION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ULTRACENTRIFUGATION; CELL MEMBRANE; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; FLOW CYTOMETRY; GENETIC TRANSFECTION; GENETICS; INTRACELLULAR SPACE; MELANOMA; METABOLISM; PATHOLOGY; PHOSPHORYLATION; THIN LAYER CHROMATOGRAPHY; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CHROMATOGRAPHY, THIN LAYER; CRK-ASSOCIATED SUBSTRATE PROTEIN; FLOW CYTOMETRY; GANGLIOSIDE GALACTOSYLTRANSFERASE; GANGLIOSIDES; HUMANS; INTRACELLULAR SPACE; MELANOMA; MEMBRANE MICRODOMAINS; PAXILLIN; PHOSPHORYLATION; TRANSFECTION;

EID: 77956008635     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01613.x     Document Type: Article

References (31)

1. Wiegandt H. Gangliosides. Glycolipids 1985, 199-260. Wiegandt H. eds, New York, Elsevier
2. Hakomori S, Igarashi Y. Gangliosides and glycosphingolipids as modulators of cell growth, adhesion, and transmembrane signaling. Adv Lipid Res 1993, 25:147-62.
3. Furukawa K, Lloyd KO. Gangliosides in melanoma. Human Melanoma: From Basic Research to Clinical Application 1990, 15-30. Ferrone S, ed, Heidelberg, Springer
4. Furukawa K, Arita Y, Satomi N, Eisinger M, Lloyd KO. Tumor necrosis factor enhances GD3 ganglioside expression in cultured human melanocytes. Arch Biochem Biophys 1990, 281:70-5.
5. Houghton AN, Mintzer D, Cordon-Cardo C. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. Proc Natl Acad Sci USA 1985, 82:1242-6.
6. Forero A, Shah J, Carlisle R. A phase I study of an anti-GD3 monoclonal antibody, KW-2871, in patients with metastatic melanoma. Cancer Biother Radiopharm 2006, 21:561-8.
7. Hamamura K, Furukawa K, Hayashi T. Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells. Proc Natl Acad Sci USA 2005, 102:11041-6.
8. Nakashima H, Hamamura K, Houjou T. Overexpression of caveolin-1 in a human melanoma cell line results in dispersion of ganglioside GD3 from lipid rafts and alteration of leading edges, leading to attenuation of malignant properties. Cancer Sci 2007, 98:512-20.
9. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569-72.
10. Miyazaki H, Furukawa K, Fukumoto S, Okada M, Hasegawa T, Furukawa K. Expression Cloning of Rat cDNA Encoding UDP-galactose: GD2 b1,3-galactosyl-transferase That Determines the Expression of GD1b/GM1/GA1. J Biol Chem 1997, 272:24794-9.
11. Mitsuda T, Furukawa K, Fukumoto S, Miyazaki H, Urano T, Furukawa K. Overexpression of ganglioside GM1 results in the dispersion of platelet-derived growth factor receptor from glycolipid-enriched micro-domains and in the suppression of cell growth signals. J Biol Chem 2002, 277:11239-46.
12. Zhang Q, Furukawa K, Chen HH, Sakakibara T, Urano T, Furukawa K. Metastatic potential of mouse Lewis lung cancer cells is regulated via ganglioside GM1 by modulating the matrix metalloprotease-9 localization in lipid rafts. J Biol Chem 2006, 281:18145-55.
13. Zhao J, Furukawa K, Fukumoto S. Attenuation of interleukin 2 signal in the spleen cells of complex ganglioside-lacking mice. J Biol Chem 1999, 274:13744-7.
14. Yoshida S, Fukumoto S, Kawaguchi H, Sato S, Ueda R, Furukawa K. Ganglioside G(D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis. Cancer Res 2001, 61:4244-52.
15. Furukawa K, Clausen H, Hakomori S. Analysis of the specificity of five murine anti-blood group A monoclonal antibodies, including one that identifies type 3 and type 4 A determinants. Biochemistry 1985, 24:7820-6.
16. Ikeda K, Shimizu T, Taguchi R. Targeted analysis of ganglioside and sulfatide molecular species by LC/ESI-MS/MS with theoretically expanded multiple reaction monitoring. J Lipid Res 2008, 49:2678-89.
17. Byrdwell WC, Perry RH. Liquid chromatography with dual parallel mass spectrometry and 31P nuclear magnetic resonance spectroscopy for analysis of sphingomyelin and dihydrosphingomyelin. II. Bovine milk sphingolipids. J Chromatogr A 2007, 1146:164-85.
18. Pukel CS, Lloyd KO, Travassos LR, Dippold WG, Oettgen HF, Old LJ. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody. J Exp Med 1982, 155:1133-47.
19. Saito M, Yu RK, Cheung NK. Ganglioside GD2 specificity of mono-clonal antibodies to human neuroblastoma cell. Biochem Biophys Res Commun 1985, 127:1-7.
20. Siddiqui B, Buehler J, DeGregorio MW, Macher BA. Differential expression of ganglioside GD3 by human leukocytes and leukemia cells. Cancer Res 1984, 44:5262-5.
21. Merritt WD, Casper JT, Lauer SJ, Reaman GH. Expression of GD3 ganglioside in childhood T-cell lymphoblastic malignancies. Cancer Res 1987, 47:1724-30.
22. Okada M, Itoh Mi M, Haraguchi M. b-series ganglioside deficiency exhibits no definite changes in the neurogenesis and the sensitivity to Fas-mediated apoptosis, but impairs regeneration of the lesioned hypoglossal nerve. J Biol Chem 2002, 277:1633-6.
23. Furukawa K, Akagi T, Nagata Y. GD2 ganglioside on human T-lymphotropic virus type I-infected T cells: possible activation of β-1,4-N-acetylgalactosaminyltransferase gene by p40tax. Proc Natl Acad Sci USA 1993, 90:1972-6.
24. Furukawa K, Tsuchida A, Okajima T, Furukawa K. Glycoconjugate glycosyltransferases. Glycoconj J 2009, 26:987-98.
25. Hullin-Matsuda F, Kobayashi T. Monitoring the distribution and dynamics of signaling microdomains in living cells with lipid-specific probes. Cell Mol Life Sci 2007, 64:2492-504.
26. Lencer WI, Hirst TR, Holmes RK. Membrane traffic and the cellular uptake of cholera toxin. Biochim Biophys Acta 1999, 1450:177-90.
27. Schroeder F, Atshaves BP, McIntosh AL. Sterol carrier protein-2: new roles in regulating lipid rafts and signaling. Biochim Biophys Acta 2007, 1771:700-18.
28. Nishio M, Fukumoto S, Furukawa K. Over-expressed GM1 suppresses NGF signals by modulating the intra-cellular localization of NGF receptors and membrane fluidity in PC12 cells. J Biol Chem 2004, 279:33368-78.
29. Hamamura K, Tsuji M, Ohkawa Y. Focal adhesion kinase as well as p130Cas and paxillin is crucially involved in the enhanced malignant properties under expression of ganglioside GD3 in melanoma cells. Biochim Biophys Acta 2008, 1780:513-19.
30. Ohkawa Y, Miyazaki S, Miyata M, Hamamura K, Furukawa K, Furukawa K. Essential roles of integrin-mediated signaling for the enhancement of malignant properties of melanomas based on the expression of GD3. Biochem Biophys Res Commun 2008, 373:14-19.
31. Teti A, Migliaccio S, Baron R. The role of the alphaVbeta3 integrin in the development of osteolytic bone metastases: a pharmacological target for alternative therapy? Calcif Tissue Int 2002, 71:293-9.